Treatment of Nausea and Vomiting in Chemotherapy
-Tramèr M.R et al. Cannabinoids for control
of chemotherapy induced nausea and vomiting: quantitative
systematic review. BMJ, 323 (2001):16-24
-Kwiatkowska M, Parker LA, Burton P, Mechoulam R.
A comparative analysis of the potential of cannabinoids
and ondansetron to suppress cisplatin-induced emesis
in the Suncus murinus. Psychopharmacology (Berl) 2004
Jan 22
-Stimolazione dell'appetito nell'AIDSV.Di Marzo et
al. Leptin-regulated endocannabinoids are involved
in maintaining food intake. Nature 410, 822 - 825
(2001)
-Abrams et al. Short-term effects of cannabinoids
in patients with HIV-1 infection: a randomized, placebo-controlled
clinical trial. Ann Intern Med. 2003 Aug 19;139(4):258-66.
-Marijuana Use and Its Association With Adherence
to Antiretroviral Therapy Among HIV-Infected Persons
With Moderate to Severe Nausea. J Acquir Immune Defic
Syndr. 2005 Jan 1;38(1):43-46.
Multiple Sclerosis
-Baker D et al Cannabinoids control spasticity and
tremor in a multiple sclerosis model. Nature 2000;404:
84 - 87
-Achiron J et al. Dexanabinol (HU-211) - effect on
experimental autoimmune encephalomyelitis: implications
for the treatment of acute relapses of multiple sclerosis.
Journal of Neuroimmunology 2000;102: 26-31.
-Pryce G, et al. Cannabinoids inhibit neurodegeneration
in models of multiple sclerosis. Brain.2003; 126:
2191-2202
-John Zajicek et al. on behalf of the UK MS Research
Group. Cannabinoids for treatment of spasticity and
other symptoms related to multiple sclerosis (CAMS
study): multicentre randomised placebo-controlled
trial. Lancet 2003 Nov 8;362(9395):1517-1526.
-C.Vaney et al. Efficacy, safety and tolerability
of an orally administered cannabis extract in the
treatment of spasticity in patients with multiple
sclerosis: a randomized, double-blind, placebo-controlled,
crossover study. Multiple Sclerosis 2004, 10 ; 417.
-DT Wade et al. Do cannabis-based medicinal extracts
have general or specific effects on symptoms in multiple
sclerosis? A double-blind, randomized, placebo-controlled
study on 160 patients. Multiple Sclerosis 2004, 10
; 434.
Pain Treatment
-Meng ID et al. An analgesia circuit activated by
cannabinoids. Nature 1998; 395(6700):381-3.
-Russo EB. Cannabis for migraine treatment: the once
and future prescription? A historical and scientific
review. Pain 1998:76(1-2):3-8.
-Campbell FA et al. Are cannabinoids an effective
and safe treatment option in the management of pain?
A qualitative systematic review. BMJ 2001; 323 (7
July): 1-6
-Helyes Z, et al. Inhibitory effect of anandamide
on resiniferatoxin-induced sensory neuropeptide release
in vivo and neuropathic hyperalgesia in the rat. Life
Sci 2003 Sep 19;73(18):2345-53
-Berman J. et al. Efficacy of two cannabis-based medicinal
extracts for relief of central neuropathic pain from
brachial plexus avulsion: results of a randomised
controlled trial. Anaesthesia, 2003;58:938
-Notcutt W, et al. Initial experiences with medicinal
extracts of cannabis for chronic pain: Results from
34 'N of 1' studies. Anaesthesia 2004 May;59(5):440-52)
-Berman JS, Symonds C, Birch R. Efficacy of two cannabis
based medicinal extracts for relief of central neuropathic
pain from brachial plexus avulsion: results of a randomised
controlled trial. -Pain. 2004 Dec;112(3):299-306.
